|
Volumn 57, Issue 2, 2002, Pages
|
PBMs: Ripe for regulation
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GENERIC DRUG;
TAMOXIFEN;
COST CONTROL;
DRUG COST;
DRUG INDUSTRY;
DRUG MANUFACTURE;
FOOD AND DRUG ADMINISTRATION;
HEALTH ECONOMICS;
HEALTH INSURANCE;
HUMAN;
MEDICAID;
MEDICARE;
PHARMACIST;
PHYSICIAN;
PRESCRIPTION;
PRIVACY;
REVIEW;
RISK MANAGEMENT;
CONFLICT OF INTEREST;
DRUG INDUSTRY;
FRAUD;
GOVERNMENT AGENCIES;
HUMANS;
INSURANCE, PHARMACEUTICAL SERVICES;
MANAGED CARE PROGRAMS;
MEDICARE;
PHARMACEUTICAL PREPARATIONS;
PHARMACISTS;
POLITICS;
PRIVACY;
QUALITY ASSURANCE, HEALTH CARE;
UNITED STATES;
|
EID: 18644378192
PISSN: 1064590X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (2)
|
References (0)
|